These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

455 related items for PubMed ID: 28916481

  • 1. Identification of 2,4-dihydroxy-5-pyrimidinyl imidothiocarbomate as a novel inhibitor to Y box binding protein-1 (YB-1) and its therapeutic actions against breast cancer.
    Gunasekaran VP, Nishi K, Sivakumar D, Sivaraman T, Mathan G.
    Eur J Pharm Sci; 2018 Apr 30; 116():2-14. PubMed ID: 28916481
    [Abstract] [Full Text] [Related]

  • 2. Y-box binding protein 1 is up-regulated in proliferative breast cancer and its inhibition deregulates the cell cycle.
    Yu YN, Yip GW, Tan PH, Thike AA, Matsumoto K, Tsujimoto M, Bay BH.
    Int J Oncol; 2010 Aug 30; 37(2):483-92. PubMed ID: 20596676
    [Abstract] [Full Text] [Related]

  • 3. Quercetin reversed MDR in breast cancer cells through down-regulating P-gp expression and eliminating cancer stem cells mediated by YB-1 nuclear translocation.
    Li S, Zhao Q, Wang B, Yuan S, Wang X, Li K.
    Phytother Res; 2018 Aug 30; 32(8):1530-1536. PubMed ID: 29635751
    [Abstract] [Full Text] [Related]

  • 4. YBX1 gene silencing inhibits migratory and invasive potential via CORO1C in breast cancer in vitro.
    Lim JP, Shyamasundar S, Gunaratne J, Scully OJ, Matsumoto K, Bay BH.
    BMC Cancer; 2017 Mar 16; 17(1):201. PubMed ID: 28302118
    [Abstract] [Full Text] [Related]

  • 5. YB-1 expression promotes epithelial-to-mesenchymal transition in prostate cancer that is inhibited by a small molecule fisetin.
    Khan MI, Adhami VM, Lall RK, Sechi M, Joshi DC, Haidar OM, Syed DN, Siddiqui IA, Chiu SY, Mukhtar H.
    Oncotarget; 2014 May 15; 5(9):2462-74. PubMed ID: 24770864
    [Abstract] [Full Text] [Related]

  • 6. The YB-1/EZH2/amphiregulin signaling axis mediates LPA-induced breast cancer cell invasion.
    Cho KH, Jeong BY, Park CG, Lee HY.
    Arch Pharm Res; 2019 Jun 15; 42(6):519-530. PubMed ID: 31004257
    [Abstract] [Full Text] [Related]

  • 7. Y box binding protein 1 inhibition as a targeted therapy for ovarian cancer.
    Tailor D, Resendez A, Garcia-Marques FJ, Pandrala M, Going CC, Bermudez A, Kumar V, Rafat M, Nambiar DK, Honkala A, Le QT, Sledge GW, Graves E, Pitteri SJ, Malhotra SV.
    Cell Chem Biol; 2021 Aug 19; 28(8):1206-1220.e6. PubMed ID: 33713600
    [Abstract] [Full Text] [Related]

  • 8. PH006, a novel and selective Src kinase inhibitor, suppresses human breast cancer growth and metastasis in vitro and in vivo.
    Ma JG, Huang H, Chen SM, Chen Y, Xin XL, Lin LP, Ding J, Liu H, Meng LH.
    Breast Cancer Res Treat; 2011 Nov 19; 130(1):85-96. PubMed ID: 21181437
    [Abstract] [Full Text] [Related]

  • 9. The phosphoinositide-dependent kinase-1 inhibitor 2-amino-N-[4-[5-(2-phenanthrenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl]phenyl]-acetamide (OSU-03012) prevents Y-box binding protein-1 from inducing epidermal growth factor receptor.
    To K, Zhao Y, Jiang H, Hu K, Wang M, Wu J, Lee C, Yokom DW, Stratford AL, Klinge U, Mertens PR, Chen CS, Bally M, Yapp D, Dunn SE.
    Mol Pharmacol; 2007 Sep 19; 72(3):641-52. PubMed ID: 17595327
    [Abstract] [Full Text] [Related]

  • 10. The increased expression of Y box-binding protein 1 in melanoma stimulates proliferation and tumor invasion, antagonizes apoptosis and enhances chemoresistance.
    Schittek B, Psenner K, Sauer B, Meier F, Iftner T, Garbe C.
    Int J Cancer; 2007 May 15; 120(10):2110-8. PubMed ID: 17266041
    [Abstract] [Full Text] [Related]

  • 11. Increased nuclear localization of transcription factor Y-box binding protein 1 accompanied by up-regulation of P-glycoprotein in breast cancer pretreated with paclitaxel.
    Fujita T, Ito K, Izumi H, Kimura M, Sano M, Nakagomi H, Maeno K, Hama Y, Shingu K, Tsuchiya S, Kohno K, Fujimori M.
    Clin Cancer Res; 2005 Dec 15; 11(24 Pt 1):8837-44. PubMed ID: 16361573
    [Abstract] [Full Text] [Related]

  • 12. p53 Suppresses lung resistance-related protein expression through Y-box binding protein 1 in the MCF-7 breast tumor cell line.
    Tian B, Liu J, Liu B, Dong Y, Liu J, Song Y, Sun Z.
    J Cell Physiol; 2011 Dec 15; 226(12):3433-41. PubMed ID: 21344396
    [Abstract] [Full Text] [Related]

  • 13. Low molecular weight heparin-based reduction-sensitive nanoparticles for antitumor and anti-metastasis of orthotopic breast cancer.
    Sun H, Cao D, Liu Y, Wang H, Ke X, Ci T.
    Biomater Sci; 2018 Jul 24; 6(8):2172-2188. PubMed ID: 29942949
    [Abstract] [Full Text] [Related]

  • 14. Nuclear expression of Y-box binding protein-1 is associated with poor prognosis in patients with pancreatic cancer and its knockdown inhibits tumor growth and metastasis in mice tumor models.
    Shinkai K, Nakano K, Cui L, Mizuuchi Y, Onishi H, Oda Y, Obika S, Tanaka M, Katano M.
    Int J Cancer; 2016 Jul 15; 139(2):433-45. PubMed ID: 26939718
    [Abstract] [Full Text] [Related]

  • 15. The pyrrolopyrimidine colchicine-binding site agent PP-13 reduces the metastatic dissemination of invasive cancer cells in vitro and in vivo.
    Gilson P, Couvet M, Vanwonterghem L, Henry M, Vollaire J, Baulin V, Werner M, Orlowska A, Josserand V, Mahuteau-Betzer F, Lafanechère L, Coll JL, Busser B, Hurbin A.
    Biochem Pharmacol; 2019 Feb 15; 160():1-13. PubMed ID: 30529691
    [Abstract] [Full Text] [Related]

  • 16. Oridonin synergistically enhances the anti-tumor efficacy of doxorubicin against aggressive breast cancer via pro-apoptotic and anti-angiogenic effects.
    Li J, Wu Y, Wang D, Zou L, Fu C, Zhang J, Leung GP.
    Pharmacol Res; 2019 Aug 15; 146():104313. PubMed ID: 31202781
    [Abstract] [Full Text] [Related]

  • 17. Silencing of Y-box binding protein-1 by RNA interference inhibits proliferation, invasion, and metastasis, and enhances sensitivity to cisplatin through NF-κB signaling pathway in human neuroblastoma SH-SY5Y cells.
    Wang H, Sun R, Chi Z, Li S, Hao L.
    Mol Cell Biochem; 2017 Sep 15; 433(1-2):1-12. PubMed ID: 28382490
    [Abstract] [Full Text] [Related]

  • 18. Algerian Propolis Potentiates Doxorubicin Mediated Anticancer Effect Against Human Pancreatic PANC-1 Cancer Cell Line through Cell Cycle Arrest, Apoptosis Induction and P-Glycoprotein Inhibition.
    Rouibah H, Kebsa W, Lahouel M, Zihlif M, Ahram M, Aburmeleih B, Mustafa E, Al-Ameer HJ.
    Anticancer Agents Med Chem; 2018 Sep 15; 18(3):375-387. PubMed ID: 29318976
    [Abstract] [Full Text] [Related]

  • 19. SIRT7 depletion inhibits cell proliferation, migration, and increases drug sensitivity by activating p38MAPK in breast cancer cells.
    Chen KL, Li L, Yang FX, Li CM, Wang YR, Wang GL.
    J Cell Physiol; 2018 Sep 15; 233(9):6767-6778. PubMed ID: 29231244
    [Abstract] [Full Text] [Related]

  • 20. [Connection of intracellular protein YB-1 localization in cell cultures of human tumors with multidrug resistance].
    Rybalkina EIu, Stromskaia TP, Ovchinnikov LP, Stavrovskaia AA.
    Vopr Onkol; 2013 Sep 15; 59(5):623-8. PubMed ID: 24260892
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.